Picture of Biostage logo

BSTG Biostage Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+10.1%
3m+23.35%
6m+49.56%
1yr+162.54%
Volume Change (%)
10d/3m+3.87%
Price vs... (%)
52w High-22.44%
50d MA+5.92%
200d MA+33.99%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-476.15%
Return on Equity-13968.21%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Biostage EPS forecast chart

Profile Summary

Biostage, Inc. is a clinical-stage biotechnology company that uses cell therapy to regenerate organs inside the human body to treat cancer, trauma and birth defects. The Company's Cellframe technology uses the patient’s own stem cells from a simple adipose/fat tissue biopsy, expanded and banked, and then seeded onto a scaffold that mimics the natural dimensions of the organ being regenerated. Its product candidates include Cellspan esophageal implants, Cellspan bronchial implants and Cellspan tracheal implants. It is focused on developing its Cellspan esophageal implant for the treatment of esophageal atresia. Its esophageal implant consists of a hollow, tubular scaffold consisting of thin fibers of plastic made in the shape of the esophagus. Its Cellspan bronchial implants enable the surgeon to preserve the lung and repair the bronchus after surgical resection without debilitating outcomes and complications.

Directors

Last Annual
December 31st, 2021
Last Interim
September 30th, 2022
Incorporated
May 3rd, 2012
Public Since
October 14th, 2013
No. of Shareholders
155
No. of Employees
6
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
11,643,751

BSTG Share Price Performance

Upcoming Events for BSTG

Q4 2022 Biostage Inc Earnings Release

Q1 2023 Biostage Inc Earnings Release

Similar to BSTG

Picture of 20/20 Genesystems logo

20/20 Genesystems

us flag iconPink Sheets on Nasdaq

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of Accustem Sciences logo

Accustem Sciences

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ

Or unlock with your email

Or unlock with your email